The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
A review of the current use of rituximab in autoimmune diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Hardy, R. R., & Hayakawa, K. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.595 · Cited by 1,235
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., & McCrosky, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292704 · Cited by 1,136
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Characterization of a human B lymphocyte-specific antigen.
Stashenko, P., Nadler, L. M., Hardy, R., & Schlossman, S. F. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1678 · Cited by 1,076
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Self-citationD'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Giant-cell Granuloma of the Respiratory Tract (Wegener's Granulomatosis)
Walton, E. W. (1958) · BMJ · doi:10.1136/bmj.2.5091.265 · Cited by 930
Tolerogenic dendritic cells and the quest for transplant tolerance
Morelli, A. E., & Thomson, A. W. (2007) · Nature Reviews Immunology · doi:10.1038/nri2132 · Cited by 899
Looney, R. J., Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Arend, L. J., Sloand, J. A., Rosenblatt, J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20430 · Cited by 776
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 677
An open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
Pescovitz, M. D. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01288.x · Cited by 625
Golay, J., Zaffaroni, L., Vaccari, T., Lazzari, M., Borleri, G.-M., Bernasconi, S., Tedesco, F., Rambaldi, A., & Introna, M. (2000) · Blood · doi:10.1182/blood.v95.12.3900 · Cited by 604
An open study of B lymphocyte depletion in systemic lupus erythematosus
Leandro, M. J., Edwards, J. C., Cambridge, G., Ehrenstein, M. R., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10541 · Cited by 576
Leandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
Arnold, D. M., Dentali, F., Crowther, M. A., Meyer, R. M., Cook, R. J., Sigouin, C., Fraser, G. A., Lim, W., & Kelton, J. G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-1-200701020-00006 · Cited by 557
Stasi, R., Pagano, A., Stipa, E., & Amadori, S. (2001) · Blood · doi:10.1182/blood.v98.4.952 · Cited by 549
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
Hackstein, H., & Thomson, A. W. (2004) · Nature Reviews Immunology · doi:10.1038/nri1256 · Cited by 545
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., & Datta, S. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118643 · Cited by 517
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II study
Pijpe, J., van Imhoff, G. W., Spijkervet, F. K. L., Roodenburg, J. L. N., Wolbink, G. J., Mansour, K., Vissink, A., Kallenberg, C. G. M., & Bootsma, H. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21260 · Cited by 500
Tolerability and safety of rituximab (MabThera®)
Kimby, E. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.05.007 · Cited by 470
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
Joly, P., Mouquet, H., Roujeau, J.-C., D'Incan, M., Gilbert, D., Jacquot, S., Gougeon, M.-L., Bedane, C., Muller, R., Dreno, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067752 · Cited by 466
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
Anolik, J. H., Barnard, J., Cappione, A., Pugh‐Bernard, A. E., Felgar, R. E., Looney, R. J., & Sanz, I. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20592 · Cited by 456
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
Ahmed, A. R., Spigelman, Z., Cavacini, L. A., & Posner, M. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062930 · Cited by 456
Self-citationRituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Cross, A. H., Stark, J. L., Lauber, J., Ramsbottom, M. J., & Lyons, J.-A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.029 · Cited by 454
Rituximab for steroid-refractory chronic graft-versus-host disease
Cutler, C., Miklos, D., Kim, H. T., Treister, N., Woo, S.-B., Bienfang, D., Klickstein, L. B., Levin, J., Miller, K., Reynolds, C., et al. (2006) · Blood · doi:10.1182/blood-2006-01-0233 · Cited by 452
Keogh, K. A., Wylam, M. E., Stone, J. H., & Specks, U. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20718 · Cited by 450
Turnquist, H. R., Raimondi, G., Zahorchak, A. F., Fischer, R. T., Wang, Z., & Thomson, A. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7018 · Cited by 441
Rituximab in the treatment of dermatomyositis: An open‐label pilot study
Levine, T. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20849 · Cited by 440
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Sfikakis, P. P., Boletis, J., Lionaki, S., Vigklis, V., Fragiadaki, K., Iniotaki, A. G., & Moutsopoulos, H. Μ. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20858 · Cited by 410
Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
Stockman, J. A. (2008) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70301-4 · Cited by 404
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
Gottenberg, J.-E., Guillevin, L., Lambotte, O., Combe, B., Allanore, Y., Cantagrel, A., Larroche, C., Soubrier, M., Bouillet, L., Dougados, M., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029694 · Cited by 401
Smith, K. G. C., Jones, R. B., Burns, S. M., & Jayne, D. R. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22046 · Cited by 400
Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial
Keogh, K. A., Ytterberg, S. R., Fervenza, F. C., Carlson, K. A., Schroeder, D. R., & Specks, U. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1144oc · Cited by 399
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20
Sansonno, D., De Re, V., Lauletta, G., Tucci, F. A., Boiocchi, M., & Dammacco, F. (2003) · Blood · doi:10.1182/blood-2002-10-3162 · Cited by 370
Leandro, M. J., Cambridge, G., Edwards, J. C., Ehrenstein, M. R., & Isenberg, D. A. (2005) · Rheumatology · doi:10.1093/rheumatology/kei080 · Cited by 364
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
Koshy, M., Berger, D., & Crow, M. K. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118855 · Cited by 359
Tokunaga, M., Saito, K., Kawabata, D., Imura, Y., Fujii, T., Nakayamada, S., Tsujimura, S., Nawata, M., Iwata, S., Azuma, T., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057885 · Cited by 343
Cooper, N., Stasi, R., Cunningham‐Rundles, S., Feuerstein, M. A., Leonard, J. P., Amadori, S., & Bussel, J. B. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04889.x · Cited by 336
Self-Tolerance Checkpoints in B Lymphocyte Development
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60633-1 · Cited by 328
Mann, M. K., Maresz, K., Shriver, L. P., Tan, Y., & Dittel, B. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3447 · Cited by 316
Improvement of Sjögren's syndrome after two infusions of rituximab (anti‐CD20)
Devauchelle‐Pensec, V., Pennec, Y., Morvan, J., Pers, J., Daridon, C., Jousse‐Joulin, S., Roudaut, A., Jamin, C., Renaudineau, Y., Roué, I. Q., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22536 · Cited by 315
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A., Mouthon, L., Weill, B., Bruneval, P., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1447 · Cited by 306
Seror, R., Sordet, C., Guillevin, L., Hachulla, E., Masson, C., Ittah, M., Candon, S., Le Guern, V., Aouba, A., Sibilia, J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057919 · Cited by 305
Vigna-Perez, M., Hernández-Castro, B., Paredes-Saharopulos, O., Portales-Pérez, D., Baranda, L., Abud-Mendoza, C., & González-Amaro, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1954 · Cited by 303
Hatjiharissi, E., Xu, L., Santos, D. D., Hunter, Z. R., Ciccarelli, B. T., Verselis, S., Modica, M., Cao, Y., Manning, R. J., Leleu, X., et al. (2007) · Blood · doi:10.1182/blood-2007-01-070656 · Cited by 282
Tr1 cells: From discovery to their clinical application
Battaglia, M., Gregori, S., Bacchetta, R., & Roncarolo, M.-G. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.007 · Cited by 279
Scully, M., Cohen, H., Cavenagh, J., Benjamin, S., Starke, R., Killick, S., Mackie, I., & Machin, S. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06448.x · Cited by 267
Salvi, M., Vannucchi, G., Campi, I., Currò, N., Dazzi, D., Simonetta, S., Bonara, P., Rossi, S., Sina, C., Guastella, C., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02325 · Cited by 264
Harjunpää, Junnikkala, & Meri (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00745.x · Cited by 256
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
Levine, T. D., & Pestronk, A. (1999) · Neurology · doi:10.1212/wnl.52.8.1701 · Cited by 250
Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cells
Fallarino, F., Vacca, C., Orabona, C., Belladonna, M. L., Bianchi, R., Marshall, B., Keskin, D. B., Mellor, A. L., Fioretti, M. C., Grohmann, U., et al. (2002) · International Immunology · doi:10.1093/intimm/14.1.65 · Cited by 246
Self-citationGunnarsson, I., Sundelin, B., Jónsdóttir, T., Jacobson, S. H., Henriksson, E. W., & van Vollenhoven, R. F. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22505 · Cited by 241
Kessel, A., Ammuri, H., Peri, R., Pavlotzky, E. R., Blank, M., Shoenfeld, Y., & Toubi, E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5571 · Cited by 234
ERIKSSON, P. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01494.x · Cited by 232
Diagnosis and management of multiple sclerosis.
Calabresi, P. A. (2004) · PubMed · Cited by 230
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. W., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · PubMed · Cited by 229
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
Smolen, J. S., Keystone, E. C., Emery, P., Breedveld, F. C., Betteridge, N., Burmester, G. R., Dougados, M., Ferraccioli, G., Jaeger, U., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061002 · Cited by 228
Pedersen, I. M., Buhl, A. M., Klausen, P., Geisler, C. H., & Jurlander, J. (2002) · Blood · doi:10.1182/blood.v99.4.1314 · Cited by 219
Stasi, R., Stipa, E., Del Poeta, G., Amadori, S., Newland, A. C., & Provan, D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel098 · Cited by 219
The Neurobiology of the Opsoclonus-Myoclonus Syndrome
Pranzatelli, M. R. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199206000-00002 · Cited by 210
A Pilot Trial of Rituximab in the Treatment of Patients With Dermatomyositis
Chung, L., Genovese, M. C., & Fiorentino, D. F. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.6.763 · Cited by 210
Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A. S., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.743 · Cited by 210
Treon, S. P., Mitsiades, C., Mitsiades, N., Young, G., Doss, D., Schlossman, R., & Anderson, K. C. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200105000-00011 · Cited by 205
Sfikakis, P. P., Souliotis, V. L., Fragiadaki, K. G., Moutsopoulos, H. M., Boletis, J. N., & Theofilopoulos, A. N. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.12.006 · Cited by 202
D'Cruz, D. P. (2006) · BMJ · doi:10.1136/bmj.332.7546.890 · Cited by 200
Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia
Stasi, R., Brunetti, M., Stipa, E., & Amadori, S. (2004) · Blood · doi:10.1182/blood-2003-11-4075 · Cited by 198
Rituximab in the treatment of polyneuropathy associated with anti‐MAG antibodies
Renaud, S., Gregor, M., Fuhr, P., Lorenz, D., Deuschl, G., Gratwohl, A., & Steck, A. J. (2003) · Muscle & Nerve · doi:10.1002/mus.10359 · Cited by 192
M. Cardarelli, M. Q. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-001-0247-1 · Cited by 189
PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE
Flowers, M. E. D., Kansu, E., & Sullivan, K. M. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70111-8 · Cited by 186
Verginis, P., Li, H. S., & Carayanniotis, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7433 · Cited by 176
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Schöllkopf, C., Kjeldsen, L., Bjerrum, O. W., Mourits-Andersen, H. T., Nielsen, J. L., Christensen, B. E., Jensen, B. A., Pedersen, B. B., Taaning, E. B., Klausen, T. W., et al. (2006) · Leukemia & Lymphoma · doi:10.1080/10428190500286481 · Cited by 175
Treatment of refractory chronic GVHD with rituximab: a GITMO study
Zaja, F., Bacigalupo, A., Patriarca, F., Stanzani, M., Van Lint, M. T., Filì, C., Scimè, R., Milone, G., Falda, M., Vener, C., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705725 · Cited by 170
Ng, K. P., Cambridge, G., Leandro, M. J., Edwards, J. C. W., Ehrenstein, M., & Isenberg, D. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.067124 · Cited by 160
Taylor, R. P., & Lindorfer, M. A. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0424 · Cited by 159
El Fassi, D., Nielsen, C. H., Bonnema, S. J., Hasselbalch, H. C., & Hegedüs, L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2388 · Cited by 159
Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.
Andersson, J., Björk, L., Skansén-Saphir, U., et al. (1993) · PubMed · Cited by 146
B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus
Marks, S. D., Patey, S., Brogan, P. A., Hasson, N., Pilkington, C., Woo, P. M., & Tullus, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21351 · Cited by 144
Guidelines on the Use of Intravenous Immune Globulin for Neurologic Conditions
Feasby, T. E., Banwell, B., Benstead, T. J., Bril, V., Brouwers, M. C., Freedman, M. S., Hahn, A. F., Hume, H. A., Freedman, J., Pi, D., et al. (2007) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2007.01.002 · Cited by 140
Selenko-Gebauer, N., Majdic, O., Draxler, S., Berer, A., Jaeger, U., Knapp, W., & Stöckl, J. (2001) · Leukemia · doi:10.1038/sj.leu.2402226 · Cited by 139
Rituximab (anti-CD20) Adjunctive Therapy for Opsoclonus-Myoclonus Syndrome
Pranzatelli, M. R., Tate, E. D., Travelstead, A. L., Barbosa, J. L., Bergamini, R. A., Civitello, L. A., Franz, D. N., Greffe, B. S., Hanson, R. D., Hurwitz, C. A., et al. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000212991.64435.f0 · Cited by 136
Structural Basis for Recognition of CD20 by Therapeutic Antibody Rituximab
Du, J., Wang, H., Zhong, C., Peng, B., Zhang, M., Li, B., Huo, S., Guo, Y., & Ding, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701654200 · Cited by 134
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
Shaw, T., Quan, J., & Totoritis, M. C. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii55 · Cited by 126
High-dose rituximab and anti-MAG–associated polyneuropathy
Renaud, S., Fuhr, P., Gregor, M., Schweikert, K., Lorenz, D., Daniels, C., Deuschl, G., Gratwohl, A. A., & Steck, A. J. (2006) · Neurology · doi:10.1212/01.wnl.0000201193.00382.b3 · Cited by 126
A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus
Tanaka, Y., Yamamoto, K., Takeuchi, T., Nishimoto, N., Miyasaka, N., Sumida, T., Shima, Y., Takada, K., Matsumoto, I., Saito, K., et al. (2007) · Modern Rheumatology · doi:10.1007/s10165-007-0565-z · Cited by 126
Rituximab in the treatment of adult acquired hemophilia A: A systematic review
Franchini, M. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.11.004 · Cited by 121
Beck, C. E., Nathan, P. C., Parkin, P. C., Blanchette, V. S., & Macarthur, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.032 · Cited by 121
de Souza, V. R., Carreno, M., Kaveri, S. V., Ledur, A., Sadeghi, H. M., Cavaillon, J., Kazatchkine, M. D., & Haeffner‐Cavaillon, N. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250521 · Cited by 118
Lefebvre, M.-L., Krause, S. W., Salcedo, M., & Nardin, A. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000203081.43235.d7 · Cited by 111
Benedetti, L., Briani, C., Grandis, M., Vigo, T., Gobbi, M., Ghiglione, E., Carpo, M., Cocito, D., Caporale, C. M., Sormani, M. P., et al. (2007) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2007.00129.x · Cited by 106
Diagnosis and Treatment of Graves Disease
Streetman, D. D., & Khanderia, U. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c299 · Cited by 106
Achiron, A., Kishner, I., Sarova-Pinhas, I., Raz, H., Faibel, M., Stern, Y., Lavie, M., Gurevich, M., Dolev, M., Magalashvili, D., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1515 · Cited by 104
Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience
Carcao, M. D., Louis, J. S., Poon, M., Grunebaum, E., LACROIX, S., Stain, A. M., Blanchette, V. S., & Rivard, G. (2005) · Haemophilia · doi:10.1111/j.1365-2516.2005.01170.x · Cited by 101
Aydar, Y., Sukumar, S., Szakal, A. K., & Tew, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5358 · Cited by 93
In vivo activation of naive T cells by antigen-presenting B cells.
Morris, S. C., Lees, A., & Finkelman, F. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3777 · Cited by 91
Manger, K., Repp, R., Jansen, M., Geisselbrecht, M., Wassmuth, R., WESTERDAAL, N. A. C., Pfahlberg, A. B., Manger, B., Kalden, J. R., & van de Winkel, J. G. J. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.9.786 · Cited by 85
Sato, T., Ishikawa, S., Akadegawa, K., Ito, T., Yurino, H., Kitabatake, M., Yoneyama, H., & Matsushima, K. (2004) · European Journal of Immunology · doi:10.1002/eji.200425373 · Cited by 77
Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis
Toubi, E., Kessel, A., Slobodin, G., Boulman, N., Pavlotzky, E., Zisman, D., Rozenbaum, M., & Rosner, I. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062505 · Cited by 75
Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
Scheinberg, M. A., Hamerschlak, N., Kutner, J. M., Ribeiro, A. A. F., Ferreira, E., Goldenberg, J., Kiss, M. H. B., & Chahade, W. H. (2006) · PubMed · Cited by 59
A review of rituximab in cutaneous medicine
Scheinfeld, N. S. (2006) · Dermatology Online Journal · doi:10.5070/d34ns1k655 · Cited by 57
Stern, J. N. H., Keskin, D. B., Zhang, H., Lv, H., Kato, Z., & Strominger, J. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712131105 · Cited by 56
Self-citationGürcan, H. M., & Ahmed, A. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k037 · Cited by 51
Self-citationRituximab and Wegener's granulomatosis: Are B cells a target in vasculitis treatment?
Sneller, M. C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20717 · Cited by 48
Stern, J. N. H., Illés, Z., Reddy, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403832101 · Cited by 48
Self-citationHaas, J., Maas-Enríquez, M., & Hartung, H. ‐. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1224oa · Cited by 45
Eisenberg, R. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042648 · Cited by 45
Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients.
Bussel, J. B. (2000) · PubMed · Cited by 44
Idiopathic Thrombocytopenic Purpura in Adults
Provan, D., & Newland, A. C. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200312001-00008 · Cited by 42
Six refractory lupus patients treated with rituximab: A case series
Gillis, J. Z., Dall’Era, M., Gross, A., Yazdany, J., & Davis, J. C. (2007) · Arthritis Care & Research · doi:10.1002/art.22629 · Cited by 38
Response to Rituximab in Patients with Type II Cryoglobulinemia
Bryce, A. H., Dispenzieri, A. A., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., Inwards, D. J., Yasenchak, C. A., Kumar, S. K., & Gertz, M. A. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.n.052 · Cited by 38
Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma
Collins‐Burow, B. M., & Santos, E. S. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.3.257 · Cited by 26
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Floßmann, O., Jones, R. B., Jayne, D. R. W., & Luqmani, R. A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048900 · Cited by 22
Will targeting B cells be the answer for Sjögren's syndrome?
Looney, R. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22604 · Cited by 21
Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
Eisenberg, R. A. (2006) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006779025757 · Cited by 21
Copolymer effects on microglia and T cells in the central nervous system of humanized mice
Illés, Z., Stern, J. N. H., Keskin, D. B., Reddy, J., Brosnan, C. F., Waldner, H., Santambrogio, L., Kuchroo, V. K., & Strominger, J. L. (2005) · European Journal of Immunology · doi:10.1002/eji.200526121 · Cited by 17
Self-citationLawrence (1998) · doi:10.1002/1529-0131(199805)41:5<778::aid-art4>3.0.co;2-v
Cited by
Mössner, E., Brünker, P., Moser, S., Püntener, U., Schmidt, C., Herter, S., Grau, R., Gerdes, C., Nopora, A., van Puijenbroek, E., et al. (2010) · Blood · doi:10.1182/blood-2009-06-225979 · Cited by 981
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 590
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
Matsumoto, M., Baba, A., Yokota, T., Nishikawa, H., Ohkawa, Y., Kayama, H., Kallies, A., Nutt, S. L., Sakaguchi, S., Takeda, K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.016 · Cited by 556
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Meijer, J. M., Meiners, P. M., Vissink, A., Spijkervet, F. K. L., Abdulahad, W., Kamminga, N., Brouwer, E., Kallenberg, C. G. M., & Bootsma, H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27314 · Cited by 488
Metadata
- Authors
- Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 9
- Issue
- 1
- Pages
- 10-25
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2063470653
- Cited by
- 314
- References
- 133
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.